Persistence of preleukemic clones in acute myeloid leukemia (AML) complete remission
Are combination therapies more effective for the treatment of relapsed refractory CLL?
The challenges associated with managing multiple myeloma patients on immunotherapy
Ignacio Melero Bermejo
AML17 trial update: FLT3-ITD mutation and daunorubicin dosage
Using PET to determine treatment response in Hodgkin lymphoma